Scarica l'app Stockscreener
4.52
5.24%
-0.25
Dopo l'orario di chiusura:
4.52
Precedente Chiudi:
$4.77
Aprire:
$4.77
Volume 24 ore:
1.53M
Relative Volume:
1.13
Capitalizzazione di mercato:
$625.04M
Reddito:
-
Utile/perdita netta:
$-45.44M
Rapporto P/E:
-12.91
EPS:
-0.35
Flusso di cassa netto:
$-42.28M
1 W Prestazione:
+11.06%
1M Prestazione:
+25.21%
6M Prestazione:
+165.88%
1 anno Prestazione:
+128.28%
Intervallo 1D:
$4.43
$4.86
Intervallo di 1 settimana:
$4.00
$4.86
Portata 52W:
$1.27
$4.86
Compass Therapeutics Inc Stock (CMPX) Company Profile
Nome
Compass Therapeutics Inc
Settore
Industria
Telefono
617-500-8099
Indirizzo
80 GUEST STREET, BOSTON
Confronta CMPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
4.52 | 744.62M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2025-04-02 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Iniziato | Guggenheim | Buy |
| 2025-02-19 | Iniziato | Piper Sandler | Overweight |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Iniziato | Jefferies | Buy |
| 2023-01-27 | Iniziato | Stifel | Buy |
| 2022-05-23 | Ripresa | H.C. Wainwright | Buy |
| 2022-03-15 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-01-19 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Raymond James | Outperform |
| 2021-12-20 | Iniziato | SVB Leerink | Outperform |
| 2021-12-15 | Iniziato | Wedbush | Outperform |
Mostra tutto
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Will Compass Therapeutics Inc. stock outperform growth indexes2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
Is Compass Therapeutics Inc. stock reversal real or fakeTrade Entry Summary & Scalable Portfolio Growth Ideas - newser.com
Risk adjusted return profile for Compass Therapeutics Inc. analyzedMarket Trend Report & Trade Opportunity Analysis - newser.com
How to monitor Compass Therapeutics Inc. with trend dashboardsQuarterly Investment Review & AI Forecasted Stock Moves - newser.com
Using fundamentals and technicals on Compass Therapeutics Inc.Trade Ideas & Community Trade Idea Sharing - newser.com
Key resistance and support levels for Compass Therapeutics Inc.July 2025 Earnings & Reliable Trade Execution Plans - newser.com
Backtesting results for Compass Therapeutics Inc. trading strategiesQuarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
Why Compass Therapeutics Inc. stock is seen as undervalued2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
Why Compass Therapeutics, Inc. (CMPX) is Skyrocketing So Far in 2025 - MSN
Visual trend scoring systems applied to Compass Therapeutics Inc.July 2025 Outlook & Intraday High Probability Setup Alerts - newser.com
Certain Restricted Stock Units of Compass Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2025. - MarketScreener
Certain Common Stock of Compass Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2025. - MarketScreener
Compass Therapeutics (NASDAQ:CMPX) Shares Up 4.8%Here's Why - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Reaches New 1-Year HighHere's What Happened - MarketBeat
What is Lifesci Capital's Estimate for CMPX Q3 Earnings? - MarketBeat
Key metrics from Compass Therapeutics Inc.’s quarterly dataIndex Update & Precise Buy Zone Tips - newser.com
Compass Therapeutics' (CMPX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-09 04:14:15 - newser.com
Regression analysis insights on Compass Therapeutics Inc. performanceQuarterly Portfolio Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
How to use a screener to detect Compass Therapeutics Inc. breakoutsWeekly Trade Report & Verified Chart Pattern Signals - newser.com
Will Compass Therapeutics Inc. stock outperform Nasdaq indexForecast Cut & Technical Pattern Recognition Alerts - newser.com
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Lifesci Capital - Defense World
Compass Therapeutics (NASDAQ:CMPX) Now Covered by Lifesci Capital - MarketBeat
LifeSci Capital Initiates Coverage of Compass Therapeutics (CMPX) with Outperform Recommendation - Nasdaq
Will breakout in Compass Therapeutics Inc. lead to full recoveryPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Compass Therapeutics Inc. stock volume spike explainedEntry Point & Community Trade Idea Sharing Platform - newser.com
Forecasting Compass Therapeutics Inc. price range with options dataTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
Will Compass Therapeutics Inc. stock return to pre crisis levelsRate Cut & Long-Term Capital Growth Strategies - newser.com
What analysts say about Compass Therapeutics Inc stockContrarian Investment Ideas & You’ll Regret Not Buying These Early - earlytimes.in
Compass Therapeutics Inc Stock Analysis and ForecastTrading Volume Trends & Free Tap Rapid Wealth - earlytimes.in
Compass Therapeutics Inc Azioni (CMPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Compass Therapeutics Inc Azioni (CMPX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):